JOURNAL ARTICLE

Letter to Editor: Efficacy of Telitacicept in the Treatment of Sjögren's Syndrome‐Associated Interstitial Lung Disease: A Case Report.

  • Published In: International Journal of Rheumatic Diseases, 2025, v. 28, n. 5. P. 1 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Li, Mengshan; Sun, Mingfang; Chen, Xue; Zhou, Ying; Dai, Huanzi 3 of 3

Abstract

The article focuses on a case report of a 70-year-old Asian female diagnosed with Sjögren's syndrome, an autoimmune disease characterized by dryness of the eyes and mouth, which also affected her lungs and skin. Initially treated with prednisone and other therapies for her symptoms, the patient experienced limited improvement and developed severe respiratory issues. Ultimately, she was treated with a biologic agent called Telitacicept, which targets B cell activation, leading to significant improvements in her symptoms and lung function. The report highlights the potential of Telitacicept as a treatment for Sjögren's syndrome-associated pulmonary interstitial fibrosis, although further research is needed to confirm its long-term efficacy and safety. [Extracted from the article]

Additional Information

  • Source:International Journal of Rheumatic Diseases. 2025/05, Vol. 28, Issue 5, p1
  • Document Type:Article
  • Subject Area:Consumer Health
  • Publication Date:2025
  • ISSN:1756-1841
  • DOI:10.1111/1756-185X.70255
  • Accession Number:185452868
  • Copyright Statement:Copyright of International Journal of Rheumatic Diseases is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.